CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-27 | Thomas Stephen Basil Director | Option exercise | +25,094 | 204,282 | ||
| 2025-06-27 | Thomas Stephen Basil Director | Option exercise · Restricted Stock Units | −25,094 | 0 | ||
| 2025-06-20 | Pimblett Emily SVP, Finance & CAO | Sale 10b5-1 | −1,242 | $1.24 | $2K | 18,888 |
| 2025-06-18 | Pimblett Emily SVP, Finance & CAO | Option exercise 10b5-1 | +5,000 | 20,130 | ||
| 2025-06-18 | Pimblett Emily SVP, Finance & CAO | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 15,000 | ||
| 2025-06-17 | Driscoll Cindy Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | Drapkin Kimberlee C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | Cumbo Alexander Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | Dunn Judith Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | WILLIAMS DOUGLAS E Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | Levin Andrew David Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-04 | Thomas Stephen Basil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-03-31 | WILLIAMS DOUGLAS E Director | Grant or award · Stock Option (Right to Buy) | +78,873 | 78,873 | ||
| 2025-03-28 | Drapkin Kimberlee C Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-03-28 | Cumbo Alexander Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-03-27 | Thomas Stephen Basil Director | Option exercise | +25,093 | 179,188 | ||
| 2025-03-27 | Thomas Stephen Basil Director | Option exercise · Restricted Stock Units | −25,093 | 25,094 | ||
| 2025-03-20 | Pimblett Emily SVP, Finance & CAO | Sale 10b5-1 | −1,199 | $1.31 | $2K | 15,130 |
| 2025-03-18 | Pimblett Emily SVP, Finance & CAO | Option exercise 10b5-1 | +5,000 | 16,329 |
Page 3 of 9 · 166 trades